Trial intelligence / Profile preview

UCB and EPO in Children With Cerebral Palsy

NCT01991145Phase 2Completed

Start
Nov 2013
Primary completion
Jun 2017
Modality
Hematopoietic Stem Cells
Countries
1
01

Overview

A Phase 2 trial of umbilical cord blood, epoetin alfa in cerebral palsy (CP). Started Nov 2013; status: completed.

02

Drugs

umbilical cord bloodepoetin alfa
03

Conditions

cerebral palsy (CP)

Beyond the preview

Go deeper on NCT01991145.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01991145.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call